4-Aminoquinolines as Antimalarial Agents: Review of A Medicinal Chemistry Perspective
نویسندگان
چکیده
Abstract: Malaria is a potentially fatal parasitic disease brought on by five Plasmodium species, including falciparum, vivax, ovale, malariae, and knowlesi. The fast emergence of P. falciparum resistance to currently available treatments has increased health concerns in developing countries. growth emphasizes the need for novel, secure, cost-effective antimalarial drug that can treat malaria resistant multiple drugs. Therefore, it become crucial create new therapeutic approaches deal with rise parasites artemisinin. For treatment children living areas moderate high transmission, as established WHO, vaccine RTS, S been authorized. WHO recommends governments consider this immunization against human parasite when deciding optimum subnational combination measures maximum impact. current research synthesizes numerous 4-aminoquinoline derivatives successfully treating its diverse etiological species. Additionally management prevention are antibiotics. Effective well-tolerated medications include tetracycline chloramphenicol, chloroquine, primaquine, pamaquine, artemisinins some drugs used malaria; however, compounds have proven be even more efficient. This review, based literature reports, will give medicinal chemists ideas develop. In addition, review help search leads future.
منابع مشابه
QSAR analysis of 7-substituted 4-aminoquinolines as antimalarial agents
The emergence and rapid spread of chloroquine resistant strains of Plasmodium falciparum has dramatically reduced the chemotherapeutic options. Towards this goal, the quantitative structure-activity relationship analysis of some synthesized 7-substituted 4aminoquinolines were performed for their antiplasmodial activity against chloroquine-resistant parasites to find out the structural features ...
متن کاملNovel 4-aminoquinoline analogues as antimalarial agents: A review
Malaria remains the worlds’ most devastating human parasitic infection, afflicting 500 million people and causing from 1.7-2.5 million deaths each year globally. 4-aminoquinoline drugs are highly effective and rapidly acting agents against asexual erythrocytic stages of malaria parasites mainly P. vivax and P. falciparum responsible for life threatening clinical manifestations and severity of t...
متن کاملInhibition test of heme detoxification (ITHD) as an approach for detecting antimalarial agents in medicinal plants
Background and objectives: There are several methods to assess the in vitro capability of heme inhibitory activity of antimalarial compounds; most of them require some specific equipment or toxic substances and sometimes the needed materials are not accessible. Regarding the necessity and importance of optimizing and standardizing experimental conditions, the present s...
متن کاملN-cinnamoylated aminoquinolines as promising antileishmanial agents.
A series of cinnamic acid conjugates of primaquine and chloroquine were evaluated for their in vitro antileishmanial activities. Although primaquine derivatives had modest activity, chloroquine conjugates exhibited potent activity against both promastigotes (50% inhibitory concentration [IC50] = 2.6 to 21.8 μM) and intramacrophagic amastigotes (IC50 = 1.2 to 9.3 μM) of Leishmania infantum. Both...
متن کاملDiversity-Oriented Synthesis-Facilitated Medicinal Chemistry: Toward the Development of Novel Antimalarial Agents
Here, we describe medicinal chemistry that was accelerated by a diversity-oriented synthesis (DOS) pathway, and in vivo studies of our previously reported macrocyclic antimalarial agent that derived from the synthetic pathway. Structure-activity relationships that focused on both appendage and skeletal features yielded a nanomolar inhibitor of P. falciparum asexual blood-stage growth with impro...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: International journal of life science and pharma research
سال: 2022
ISSN: ['2250-0480']
DOI: https://doi.org/10.22376/ijlpr.2023.13.1.sp1.p83-p97